Get started
Author

Vaibhav Kadam

Observed names: Kadam Vaibhav N, Vaibhav M. Kadam
ORCID: 0009-0000-1493-6369
Observed ORCID: 0009-0000-1493-6369
OpenAlex ID: A5133325077
Recent advances in synthetic strategies of fourth-generation EGFR tyrosine kinase inhibitors under clinical trials for the treatment of resistant non-small cell lung cancer (NSCLC)
2026 · Vaibhav M. Kadam, Harun M. Patel · Bioorganic Chemistry · 2
Optimizing the Cardiotoxicity Profile of Osimertinib via Scaffold Hopping: An Integrated Cheminformatics and Molecular Modeling Approach
2026 · Narendra Nagpure, Vaibhav Kadam, et al. · Journal of Computational Biophysics and Chemistry · 1
Quantitative Analysis of Flavokawain a by Derivative and Area Under Curve UV-Spectrophotometry
2026 · Vaishnavi Pawar, Vaibhav Kadam, et al. · Journal of Applied Spectroscopy
Decoding the off-target neuropharmacological potential of Rivaroxaban’s Aminomethyl process impurity: An integrated computational and experimental study
2026 · Amit Shimpi, Bhatu Patil, et al. · In Silico Research in Biomedicine
Dual-Functional Mucoadhesive Films for Buccal Delivery: Integration of Permeation Enhancers with Smart Polymers for Controlled Release
2025 · Rahane Rahulkumar D, Inamdar Saniya N, et al. · International Journal of Drug Delivery Technology
PDF
Works count: 5
Citation count: 3
H-index: 1
I10-index:
Year
Topic
Type